MACROGENICS INC — Director's Dealing 2017

Jun 6, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2017-06-05

Reporting Person: Wigginton Jon Marc (Sr VP, Clinical Dev. & CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-05	Common Stock	M	5000	$4.70	Acquired	35000	Direct
2017-06-05	Common Stock	S	5000	$20	Disposed	30000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-05	Employee stock option (right to buy)	$4.7	M	5000	Disposed	2023-07-18	Common Stock (5000.0)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2016.

F2: This transaction was executed in multiple trades at prices ranging from $20 to $20.02.

F3: This amount includes 30,000 Restricted Stock Units (RSU) acquired on 2/25/16 which will vest on 2/25/18.